menu toggle

Are US payers getting to grips with cost-effectiveness analysis?

Start a conversation

An Xcenda consultant will contact you directly to discuss your needs.

Xcenda Insights

Insight

How Cencora continues to enable efficient and reliable access to seasonal vaccines

AmerisourceBergen
AmerisourceBergen
May 2025

Insight

Navigating the current healthcare legislative landscape

AmerisourceBergen
AmerisourceBergen
May 2025

People

Insight

Q&A with the Cencora Office of U.S. Public Policy and Advocacy

Lisa Harrison
AmerisourceBergen
April 2025